Literature DB >> 7081218

Family studies of plasma dopamine-beta-hydroxylase thermal stability.

J Dunnette, R Weinshilboum.   

Abstract

There are large individual variations in the thermal stability of human plasma dopamine-beta-hydroxylase (DBH). These variations are a characteristic of the DBH molecule itself. Individual subjects may be classified as those with thermolabile and those with thermostable plasma DBH. Of 362 randomly selected unrelated children, 8.01%, and of 238 randomly selected unrelated adult subjects, 5.46% had thermolabile plasma DBH. There was not a significant correlation of DBH thermolability with either sex or age on the basis of data from 230 adults and children in 53 randomly selected families. Subjects with thermolabile DBH had basal enzyme activity only about 55% of that in subjects with stable enzyme. There was not a direct relationship between DBH thermolability and the allele DBHL, the presence of which results in very low basal enzyme activity. There was a significant familial aggregation of the trait of DBH thermolability, but there was not a significant correlation of this trait among spouses. Although preliminary pedigree evaluation raised the possibility of monogenic inheritance of the trait of DBH thermolability by an autosomal recessive mechanism, three separate families in which both parents had thermolabile enzyme included offspring with thermostable DBH. All five of these offspring had very low basal plasma DBH and were presumed to be homozygous for the allele DBHL. These observations raised the possibility that the trait of plasma DBH thermolability may be inherited, and that there may be an interaction between the locus or loci responsible for thermal stability and the locus DBH.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081218      PMCID: PMC1685197     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Inheritance of very low serum dopamine-beta-hydroxylase activity.

Authors:  R M Weinshilboum; H G Schorott; F A Raymond; W H Weidman; L R Elveback
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

2.  Immunological localization of chromogranins in sheep sympathetic neurones, and their release by nerve impulses.

Authors:  L B Geffen; B G Livett; R A Rush
Journal:  J Physiol       Date:  1969-10       Impact factor: 5.182

3.  Serum dopamine-beta-hydroxylase activity.

Authors:  R Weinshilboum; J Axelrod
Journal:  Circ Res       Date:  1971-03       Impact factor: 17.367

4.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

5.  Evidence for the release of vesicle-proteins together with noradrenaline upon stimulation of the splenic nerve.

Authors:  W P de Potter; A F de Schaepdryver; E J Moerman; A D Smith
Journal:  J Physiol       Date:  1969-10       Impact factor: 5.182

6.  A sensitive enzymatic assay for dopamine- -hydroxylase.

Authors:  P B Molinoff; R Weinshilboum; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

7.  Distribution of dopamine-beta-hydroxylase in subcellular fractions of adrenal medulla.

Authors:  M Oka; K Kajikawa; T Ohuchi; H Yoshida; R Imaizumi
Journal:  Life Sci       Date:  1967-03-01       Impact factor: 5.037

8.  Localization of different steps in noradrenaline synthesis to different fractions of a bovine splenic nerve homogenate.

Authors:  L Stjärne; F Lishajko
Journal:  Biochem Pharmacol       Date:  1967-09-09       Impact factor: 5.858

9.  Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves.

Authors:  R M Weinshilboum; N B Thoa; D G Johnson; I J Kopin; J Axelrod
Journal:  Science       Date:  1971-12-24       Impact factor: 47.728

10.  Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples.

Authors:  J Dunnette; R Weinshilboum
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.